Key result
Low daily urine ammonium excretion was associated with a 46% higher risk of the composite outcome of death or ESRD compared to high excretion in black patients with hypertensive kidney disease.
Why the study?
Does low urine ammonium excretion predict death or ESRD in black patients with hypertensive kidney disease?
Cohort (n=1,044)
Yes
Does low urine ammonium excretion predict death or ESRD in black patients with hypertensive kidney disease?
Low daily urine ammonium excretion is an independent predictor of death, ESRD, and incident acidosis in black patients with hypertensive CKD, even among those with normal serum bicarbonate.
Answers are grounded in this paper and cite their sources.
Low urine ammonium may aid risk stratification in black hypertensive CKD; hypothesis-generating pending interventional trials.
Metabolic acidosis is associated with poor outcomes in CKD. Because impaired renal ammonium excretion is important in the pathogenesis of acidosis, urine ammonium excretion might be a better and perhaps earlier acid–base indicator of risk than serum bicarbonate, particularly in patients without acidosis. We evaluated the association between baseline ammonium excretion and clinical outcomes in African American Study of Kidney Disease and Hypertension participants ( n =1044). Median daily ammonium excretion was 19.5 (95% confidence interval [95% CI], 6.5 to 43.2) mEq. In Cox regression models (adjusted for demographics, measured GFR, proteinuria, body mass index, net endogenous acid production, and serum potassium and bicarbonate), hazard ratios of the composite outcome of death or dialysis were 1.46 (95% CI, 1.13 to 1.87) in the low tertile and 1.14 (95% CI, 0.89 to 1.46) in the middle tertile of daily ammonium excretion compared with the high tertile. Among participants without acidosis at baseline, the adjusted hazard ratio for those with ammonium excretion <20 mEq/d was 1.36 (95% CI, 1.09 to 1.71) compared with those with ammonium excretion ≥20 mEq/d. Additionally, compared with participants in the high ammonium tertile, those in the low ammonium tertile had higher adjusted odds of incident acidosis at 1 year (adjusted odds ratio, 2.56; 95% CI, 1.04 to 6.27). In conclusion, low ammonium excretion is associated with death and renal failure in hypertensive kidney disease, even among those without acidosis. Low ammonium excretion could identify patients with CKD and normal bicarbonate levels who might benefit from alkali before acidosis develops.
No takes yet. Share an insight, caveat, or question.
Raphael et al. (2017) conducted a cohort in Hypertensive Kidney Disease (n=1,044). Low daily urine ammonium excretion (lowest tertile) vs. High daily urine ammonium excretion (highest tertile) was evaluated on Composite of death or ESRD (HR 1.46, 95% CI 1.13 to 1.87). Low daily urine ammonium excretion was associated with a 46% higher risk of the composite outcome of death or ESRD compared to high excretion in black patients with hypertensive kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: